Physician profile
Marcus E Mckenzie
NPI 1588640213
$6,073.92
in general payments reported to CMS, 2019-2025
39 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $308 · 2021: $945 · 2022: $1,067 · 2023: $943 · 2024: $743 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,052 · Education: $40.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,051.83 |
| Education | $40.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,504.05 | 2019-2025 | |
| Novo Nordisk INC | $607.94 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Astellas Pharma US INC | $529.83 | 2019-2023 | Lexiscan |
| Merck Sharp & Dohme LLC | $319.69 | 2021-2025 | Verquvo, Capvaxive |
| Amarin Pharma, INC. | $282.56 | 2021-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $278.33 | 2019-2025 | Lifevest |
| Amgen INC. | $259.21 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $221.10 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $207.79 | 2022-2025 | Amvuttra |
| Regeneron Healthcare Solutions, INC. | $204.21 | 2019-2025 | Evkeeza |
| Kiniksa Pharmaceuticals International, Plc | $195.90 | 2024 | Arcalyst |
| Heartflow, INC. | $178.53 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $178.12 | 2019-2025 | Camzyos, Eliquis |
| Inspire Medical Systems, INC. | $119.98 | 2023-2025 | Inspire |
| Abbott Laboratories | $118.62 | 2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $116.56 | 2019-2025 | |
| Itamar Medical INC | $93.62 | 2022-2025 | Watchpatone |
| Philips North America LLC | $80.92 | 2023-2025 | Extended Holter |
| Bayer Healthcare Pharmaceuticals INC. | $77.49 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $57.14 | 2020-2021 | |
| Astrazeneca Pharmaceuticals Lp | $54.79 | 2020-2023 | Farxiga |
| Sanofi-Aventis U.S. LLC | $50.18 | 2019-2024 | |
| Boston Scientific Corporation | $43.69 | 2019-2021 | |
| Tactile Systems Technology INC | $38.17 | 2019-2021 | |
| Medtronic, INC. | $38.06 | 2025 | Linq II |
| Esperion Therapeutics, INC. | $30.88 | 2021 | |
| Arbor Pharmaceuticals, INC. | $27.99 | 2019-2020 | |
| Bridgebio Pharma, INC. | $25.79 | 2025 | Attruby |
| Vifor Pharma, INC. | $24.90 | 2019 | |
| Lundbeck LLC | $22.83 | 2019 | |
| Kestra Medical Technology Services, INC. | $20.53 | 2025 | Assure Wcd |
| Baxter Healthcare | $19.65 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Janssen Biotech, INC. | $19.26 | 2023 | Symtuza |
| Azurity Pharmaceuticals, INC. | $14.02 | 2024 | Edarbyclor |
| Althera Pharmaceuticals LLC | $11.59 | 2022 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Mckenzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.